U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Autosomal dominant hypophosphatemic rickets(ADHR)

MedGen UID:
83346
Concept ID:
C0342642
Disease or Syndrome
Synonyms: ADHR; HYPOPHOSPHATEMIA, AUTOSOMAL DOMINANT; VITAMIN D-RESISTANT RICKETS, AUTOSOMAL DOMINANT
SNOMED CT: Autosomal dominant hypophosphatemic rickets (237889002)
Modes of inheritance:
Autosomal dominant inheritance
MedGen UID:
141047
Concept ID:
C0443147
Intellectual Product
Source: Orphanet
A mode of inheritance that is observed for traits related to a gene encoded on one of the autosomes (i.e., the human chromosomes 1-22) in which a trait manifests in heterozygotes. In the context of medical genetics, an autosomal dominant disorder is caused when a single copy of the mutant allele is present. Males and females are affected equally, and can both transmit the disorder with a risk of 50% for each child of inheriting the mutant allele.
 
Gene (location): FGF23 (12p13.32)
 
Monarch Initiative: MONDO:0008660
OMIM®: 193100
Orphanet: ORPHA89937

Definition

Autosomal dominant hypophosphatemic rickets (ADHR) is characterized by isolated renal phosphate wasting, hypophosphatemia, and inappropriately normal 1,25-dihydroxyvitamin D3 (calcitriol) levels. Patients frequently present with bone pain, rickets, and tooth abscesses. In contrast to X-linked dominant hypophosphatemic rickets (XLH; 307800), ADHR shows incomplete penetrance, variable age at onset (childhood to adult), and resolution of the phosphate-wasting defect in rare cases (Econs et al., 1997). See also hypophosphatemic bone disease (146350). Genetic Heterogeneity of Hypophosphatemic Rickets Other forms of hypophosphatemic rickets include autosomal recessive forms, i.e., ARHR1 (241520), caused by mutation in the DMP1 gene (600980) on chromosome 4q21, and ARHR2 (613312), caused by mutation in the ENPP1 gene (173335) on chromosome 6q23. An X-linked dominant form (XLHR; 307800) is caused by mutation in the PHEX gene (300550), and an X-linked recessive form (300554) is caused by mutation in the CLCN5 gene (300008). Clinical Variability of Hypophosphatemic Rickets Hypophosphatemic rickets can be caused by disorders of vitamin D metabolism or action (see VDDR1A, 264700). A form of hypophosphatemic rickets with hypercalciuria (HHRH; 241530) is caused by mutation in the SLC34A3 gene (609826), and there is evidence that a form of hypophosphatemic rickets with hyperparathyroidism (612089) may be caused by a translocation that results in an increase in alpha-klotho levels (KLOTHO; 604824). [from OMIM]

Additional description

From MedlinePlus Genetics
Hereditary hypophosphatemic rickets is a disorder related to low levels of phosphate in the blood (hypophosphatemia). Phosphate is a mineral that is essential for the normal formation of bones and teeth.

In most cases, the signs and symptoms of hereditary hypophosphatemic rickets begin in early childhood. The features of the disorder vary widely, even among affected members of the same family. Mildly affected individuals may have hypophosphatemia without other signs and symptoms. More severely affected children experience slow growth and are shorter than their peers. They develop bone abnormalities that can interfere with movement and cause bone pain. The most noticeable of these abnormalities are bowed legs or knock knees. These abnormalities become apparent with weight-bearing activities such as walking. If untreated, they tend to worsen with time.

Other signs and symptoms of hereditary hypophosphatemic rickets can include premature fusion of the skull bones (craniosynostosis) and dental abnormalities. The disorder may also cause abnormal bone growth where ligaments and tendons attach to joints (enthesopathy). In adults, hypophosphatemia is characterized by a softening of the bones known as osteomalacia.

Researchers have described several forms of hereditary hypophosphatemic rickets, which are distinguished by their pattern of inheritance and genetic cause. The most common form of the disorder is known as X-linked hypophosphatemic rickets (XLH). It has an X-linked dominant pattern of inheritance. X-linked recessive, autosomal dominant, and autosomal recessive forms of the disorder are much rarer.

Another rare type of the disorder is known as hereditary hypophosphatemic rickets with hypercalciuria (HHRH). In addition to hypophosphatemia, this condition is characterized by the excretion of high levels of calcium in the urine (hypercalciuria).  https://medlineplus.gov/genetics/condition/hereditary-hypophosphatemic-rickets

Clinical features

From HPO
Bone pain
MedGen UID:
57489
Concept ID:
C0151825
Sign or Symptom
An unpleasant sensation characterized by physical discomfort (such as pricking, throbbing, or aching) localized to bone.
Renal phosphate wasting
MedGen UID:
335116
Concept ID:
C1845169
Finding
High urine phosphate in the presence of hypophosphatemia.
Abnormality of the lower limb
MedGen UID:
242750
Concept ID:
C1096086
Anatomical Abnormality
An abnormality of the leg.
Short stature
MedGen UID:
87607
Concept ID:
C0349588
Finding
A height below that which is expected according to age and gender norms. Although there is no universally accepted definition of short stature, many refer to "short stature" as height more than 2 standard deviations below the mean for age and gender (or below the 3rd percentile for age and gender dependent norms).
Osteomalacia
MedGen UID:
14533
Concept ID:
C0029442
Disease or Syndrome
Osteomalacia is a general term for bone weakness owing to a defect in mineralization of the protein framework known as osteoid. This defective mineralization is mainly caused by lack in vitamin D. Osteomalacia in children is known as rickets.
Rickets
MedGen UID:
48470
Concept ID:
C0035579
Disease or Syndrome
Rickets is divided into two major categories including calcipenic and phosphopenic. Hypophosphatemia is described as a common manifestation of both categories. Hypophosphatemic rickets is the most common type of rickets that is characterized by low levels of serum phosphate, resistance to ultraviolet radiation or vitamin D intake. There are several issues involved in hypophosphatemic rickets such as calcium, vitamin D, phosphorus deficiencies. Moreover, other disorder can be associated with its occurrence such as absorption defects due to pancreatic, intestinal, gastric, and renal disorders and hepatobiliary disease. Symptoms are usually seen in childhood and can be varied in severity. Severe forms may be linked to bowing of the legs, poor bone growth, and short stature as well as joint and bone pain. Hypophosphatemic rickets are associated with renal excretion of phosphate, hypophosphatemia, and mineral defects in bones. The familial type of the disease is the most common type of rickets.
Generalized muscle weakness
MedGen UID:
155433
Concept ID:
C0746674
Sign or Symptom
Generalized weakness or decreased strength of the muscles, affecting both distal and proximal musculature.
Hypophosphatemic rickets
MedGen UID:
309957
Concept ID:
C1704375
Disease or Syndrome
Rickets due to low serum phosphate concentrations, the cause of which can be nutritional or genetic. This condition is characterized by normal parathyroid hormone concentrations, usually caused by renal phosphate wasting occurring in isolation or as part of a renal tubular disorder, and characterized by resistance to treatment with ultraviolet radiation or vitamin D.
Hypophosphatemia
MedGen UID:
39327
Concept ID:
C0085682
Disease or Syndrome
An abnormally decreased phosphate concentration in the blood.
Elevated circulating alkaline phosphatase concentration
MedGen UID:
727252
Concept ID:
C1314665
Finding
Abnormally increased serum levels of alkaline phosphatase activity.
Abnormality of the dentition
MedGen UID:
78084
Concept ID:
C0262444
Finding
Any abnormality of the teeth.

Professional guidelines

PubMed

Liu C, Li X, Zhao Z, Chi Y, Cui L, Zhang Q, Ping F, Chai X, Jiang Y, Wang O, Li M, Xing X, Xia W
Osteoporos Int 2021 Apr;32(4):737-745. Epub 2020 Sep 30 doi: 10.1007/s00198-020-05649-w. PMID: 32995940

Recent clinical studies

Etiology

Mameli C, Sangiorgio A, Colombo V, Gambino M, Spaccini L, Cattaneo E, Zuccotti GV
Int J Environ Res Public Health 2021 Aug 19;18(16) doi: 10.3390/ijerph18168771. PMID: 34444516Free PMC Article
Gordon RJ, Li D, Doyle D, Zaritsky J, Levine MA
J Clin Endocrinol Metab 2020 Jul 1;105(7):2392-400. doi: 10.1210/clinem/dgaa217. PMID: 32311027Free PMC Article
Vega RA, Opalak C, Harshbarger RJ, Fearon JA, Ritter AM, Collins JJ, Rhodes JL
J Neurosurg Pediatr 2016 Jun;17(6):694-700. Epub 2016 Jan 29 doi: 10.3171/2015.10.PEDS15273. PMID: 26824597
Goldsweig BK, Carpenter TO
Curr Osteoporos Rep 2015 Apr;13(2):88-97. doi: 10.1007/s11914-015-0259-y. PMID: 25620749
Rowe PS
Cell Biochem Funct 2012 Jul;30(5):355-75. Epub 2012 May 9 doi: 10.1002/cbf.2841. PMID: 22573484Free PMC Article

Diagnosis

Mameli C, Sangiorgio A, Colombo V, Gambino M, Spaccini L, Cattaneo E, Zuccotti GV
Int J Environ Res Public Health 2021 Aug 19;18(16) doi: 10.3390/ijerph18168771. PMID: 34444516Free PMC Article
Liu C, Li X, Zhao Z, Chi Y, Cui L, Zhang Q, Ping F, Chai X, Jiang Y, Wang O, Li M, Xing X, Xia W
Osteoporos Int 2021 Apr;32(4):737-745. Epub 2020 Sep 30 doi: 10.1007/s00198-020-05649-w. PMID: 32995940
Vega RA, Opalak C, Harshbarger RJ, Fearon JA, Ritter AM, Collins JJ, Rhodes JL
J Neurosurg Pediatr 2016 Jun;17(6):694-700. Epub 2016 Jan 29 doi: 10.3171/2015.10.PEDS15273. PMID: 26824597
Goldsweig BK, Carpenter TO
Curr Osteoporos Rep 2015 Apr;13(2):88-97. doi: 10.1007/s11914-015-0259-y. PMID: 25620749
Baroncelli GI, Toschi B, Bertelloni S
Curr Opin Endocrinol Diabetes Obes 2012 Dec;19(6):460-7. doi: 10.1097/MED.0b013e328358be97. PMID: 23108197

Therapy

Kritmetapak K, Kumar R
Endocr Pract 2023 Jan;29(1):69-79. Epub 2022 Oct 7 doi: 10.1016/j.eprac.2022.09.007. PMID: 36210014
Miller WL, Imel EA
Horm Res Paediatr 2022;95(6):579-592. Epub 2022 Nov 29 doi: 10.1159/000527011. PMID: 36446330
Athonvarangkul D, Insogna KL
Calcif Tissue Int 2021 Jan;108(1):143-157. Epub 2020 Jun 5 doi: 10.1007/s00223-020-00705-3. PMID: 32504139
Gohil A, Imel EA
Pediatr Endocrinol Rev 2019 Sep;17(1):17-34. doi: 10.17458/per.vol17.2019.gi.fgf23anddisordersphosphate. PMID: 31599133Free PMC Article
Baroncelli GI, Toschi B, Bertelloni S
Curr Opin Endocrinol Diabetes Obes 2012 Dec;19(6):460-7. doi: 10.1097/MED.0b013e328358be97. PMID: 23108197

Prognosis

Liu C, Li X, Zhao Z, Chi Y, Cui L, Zhang Q, Ping F, Chai X, Jiang Y, Wang O, Li M, Xing X, Xia W
Osteoporos Int 2021 Apr;32(4):737-745. Epub 2020 Sep 30 doi: 10.1007/s00198-020-05649-w. PMID: 32995940
Cebeci AN, Zou M, BinEssa HA, Alzahrani AS, Al-Rijjal RA, Al-Enezi AF, Al-Mohanna FA, Cavalier E, Meyer BF, Shi Y
J Clin Endocrinol Metab 2020 Jun 1;105(6) doi: 10.1210/clinem/dgz260. PMID: 31821448
Vega RA, Opalak C, Harshbarger RJ, Fearon JA, Ritter AM, Collins JJ, Rhodes JL
J Neurosurg Pediatr 2016 Jun;17(6):694-700. Epub 2016 Jan 29 doi: 10.3171/2015.10.PEDS15273. PMID: 26824597
Wolf M, White KE
Curr Opin Nephrol Hypertens 2014 Jul;23(4):411-9. doi: 10.1097/01.mnh.0000447020.74593.6f. PMID: 24867675Free PMC Article
Baroncelli GI, Toschi B, Bertelloni S
Curr Opin Endocrinol Diabetes Obes 2012 Dec;19(6):460-7. doi: 10.1097/MED.0b013e328358be97. PMID: 23108197

Clinical prediction guides

Liu C, Ni X, Zhao Z, Qi W, Jiang Y, Li M, Wang O, Xing X, Xia W
Bone 2023 Feb;167:116602. Epub 2022 Nov 5 doi: 10.1016/j.bone.2022.116602. PMID: 36347435
Liu C, Zhao Z, Wang O, Li M, Xing X, Hsieh E, Fukumoto S, Jiang Y, Xia W
Calcif Tissue Int 2019 Nov;105(5):476-486. Epub 2019 Sep 5 doi: 10.1007/s00223-019-00597-y. PMID: 31486862
Feng JQ, Clinkenbeard EL, Yuan B, White KE, Drezner MK
Bone 2013 Jun;54(2):213-21. Epub 2013 Feb 9 doi: 10.1016/j.bone.2013.01.046. PMID: 23403405Free PMC Article
Yu X, White KE
Ther Apher Dial 2005 Aug;9(4):308-12. doi: 10.1111/j.1744-9987.2005.00287.x. PMID: 16076372
Rowe PS
Crit Rev Oral Biol Med 2004 Sep 1;15(5):264-81. doi: 10.1177/154411130401500503. PMID: 15470265Free PMC Article

Recent systematic reviews

Abu-Zaid A, Magzoub D, Aldehami MA, Behiry AA, Bhagavathula AS, Hajji R
Biol Trace Elem Res 2021 Dec;199(12):4516-4524. Epub 2021 Jan 18 doi: 10.1007/s12011-021-02598-1. PMID: 33462793

Supplemental Content

Table of contents

    Clinical resources

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...